Wegovy time to effect: what actually happens and when

The myth: you'll see dramatic results within the first fortnight

This is the misconception that causes the most disappointment. People start 0.25mg, feel perhaps a little less hungry by week two, step on the scales and see almost nothing. They conclude Wegovy isn't working for them.

It isn't working yet, that's quite different. The 0.25mg starting dose exists entirely to help your digestive system adjust. Nausea, bloating and indigestion are common when GLP-1 medicines begin; the low opening dose keeps those side effects manageable. At 0.25mg you are not on a therapeutic weight-loss dose. Think of it as the adjustment period, not the treatment itself.

The titration moves through 0.5mg, 1mg, 1.7mg and finally 2.4mg, with roughly four weeks at each step. Most people reach 2.4mg around month five. The significant appetite suppression (and the weight loss that follows it) builds progressively as the dose climbs. Expecting dramatic results in the first two weeks is like expecting a kettle to boil before it's been switched on.

If you want a broader picture of how semaglutide behaves at each stage, the effect of Wegovy page covers the physiological changes in more detail.

What you can realistically expect, and when

Weeks one to four: most people notice some appetite reduction, feeling full more quickly at meals, and possibly less interest in snacking. The scales may barely move. This is normal. The medicine is beginning to act on GLP-1 receptors in the brain and gut, slowing gastric emptying and signalling satiety, but the calorie deficit is still modest at low doses.

Weeks four to twelve: as the dose increases, appetite suppression becomes more pronounced. Weight loss of one to two pounds per week becomes achievable for many people. Gastrointestinal side effects (nausea, loose stools, burping) often settle during this phase, though they can resurge briefly after each dose step.

Months three to six: this is where the STEP 1 trial data becomes informative. Published in the New England Journal of Medicine, the trial followed 1,961 adults over 68 weeks; at six months, participants on 2.4mg had typically lost around 8–10% of body weight. The trajectory continued well beyond that point.

Beyond six months: average weight loss at 68 weeks in STEP 1 was around 15%. Results vary considerably between individuals, and weight loss often plateaus before restarting, that is a normal biological pattern, not a sign of failure. If you are concerned the medicine seems to be becoming less effective over time, a prescriber review is the right response, not stopping abruptly.

Factors that influence how quickly Wegovy takes effect

Starting weight matters. People with higher BMIs often see larger absolute losses in the first months, though percentage reductions tend to be comparable. Metabolic rate, how consistently someone follows a reduced-calorie diet alongside treatment, sleep quality and activity level all affect the pace of loss.

Adherence to the titration schedule is significant. Missing doses or taking them at inconsistent intervals disrupts the steady-state concentration the medicine needs. Wegovy is injected once weekly, and the same day each week is the standard approach, a question our prescribers hear regularly is whether missing one dose by a day or two matters. The answer depends on where in your cycle you are, and the Patient Information Leaflet covers this; we always direct those queries to the prescriber rather than give a blanket answer here.

One practical thing worth knowing: if you're wondering why someone you know seemed to respond faster, the answer is often that they were further into their titration, not that they have a different version of the medicine. Comparing timelines between people is rarely useful. If you'd like a clearer sense of when Wegovy tends to take effect at each stage of the titration, that page walks through the timeline in detail. If by week eight at your maintenance dose you're seeing no effect from Wegovy at all, that is a legitimate signal to discuss with your prescriber rather than wait out another month in silence.

Cost and access questions come up at this stage too, if you're weighing whether the investment makes sense given the timeline, the Wegovy cost context page gives an honest breakdown of what private treatment typically involves in the UK.

When to contact your prescriber or get medical help

The titration phase carries real side effects for some people. Nausea is the most common and usually eases; severe, persistent stomach pain that radiates toward the back is different, that warrants prompt medical attention given the known (though infrequent) association between GLP-1 medicines and acute pancreatitis, as highlighted in MHRA Drug Safety Updates. Dehydration from persistent vomiting or diarrhoea, signs of an allergic reaction, and significant low mood are all reasons to contact a clinician promptly rather than wait for your next review. If you want to understand the full range of Wegovy effects across the body, from appetite signalling to cardiovascular changes, that page brings together what the clinical evidence shows.

At nume, aftercare runs seven days a week precisely because questions about timing, side effects and progress don't respect office hours. If you'd like to understand whether Wegovy is right for your situation and timeline, speaking to our prescribers is the straightforward next step. There's no waiting list and no referral needed, just a free clinical consultation, reviewed the same day by a real prescriber.